Zinc in children for viral fever and urti

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Now I have comprehensive information. Let me compile a well-structured answer.

Zinc in Children: Viral Fever & URTI

1. Role in URTI / Common Cold

Efficacy — mixed and age-dependent evidence:
  • Zinc has NOT been shown to benefit viral upper respiratory symptoms in young children (infants and toddlers). The evidence is clearest in older children and adults. — Swanson's Family Medicine Review
  • In healthy older children and adults, zinc (lozenges or syrup) reduces the duration and severity of the common cold when started within 24 hours of symptom onset. People taking zinc are less likely to have cold symptoms persisting beyond 7 days of treatment. — Swanson's Family Medicine Review
  • Zinc supplementation for ≥5 months has been shown to reduce incidence, school absenteeism, and antibiotic prescriptions for children with the common cold. — Swanson's Family Medicine Review
  • Zinc lozenges can shorten pediatric colds by approximately 1 day. — Swanson's Family Medicine Review

2. Dosing for URTI

  • Zinc lozenges ≥75 mg/day, administered within 24 hours of symptom onset, reduce duration of common cold symptoms — though there is heterogeneity in the data.
  • Zinc has a bad taste and can cause nausea — important considerations for child compliance. — Textbook of Family Medicine 9e

3. Role in Viral Diarrhea / Gastroenteritis (separate indication)

This is the best-established pediatric indication:
  • Zinc supplementation as an adjunct to oral rehydration therapy (ORT) reduces severity and duration of diarrhea and decreases episodes in children — particularly in developing countries.
  • Zinc therapy also reduces diarrhea recurrence during the following 3 months.
  • Dosing: 10 mg/day for infants <6 months; 20 mg/day for children ≥6 months. — Swanson's Family Medicine Review; Goldman-Cecil Medicine

4. Viral Fever

There is no specific indication for zinc in managing fever per se. Zinc toxicity — from acute oral ingestion — can itself cause nausea, vomiting, and fever, so zinc is not an antipyretic. For fever in children with URTI, antipyretics (paracetamol/ibuprofen) remain first-line; aspirin is contraindicated due to Reye syndrome risk. — Harrison's Principles of Internal Medicine 22E

5. Evidence Quality & Caveats

AspectEvidence
URTI in young children (<5 y)Not proven beneficial
URTI in older children/adultsModest benefit (↓ duration ~1 day) if started early (<24 h)
Prophylaxis ≥5 monthsReduces cold incidence in children
Viral diarrhea in childrenWell-established benefit (WHO/UNICEF endorsed)
Fever aloneNo direct benefit
Studies on zinc and URTI have significant heterogeneity, and the Cochrane review (Singh M, Das RR. Zinc for the Common Cold. Cochrane Database Syst Rev. 2011) notes conflicting results — Harrison's 22E echoes that study results are conflicting for cold symptoms in adults.

Summary

Zinc's strongest pediatric evidence is in acute diarrheal illness, not URTI. For upper respiratory infections, zinc may modestly shorten duration in older children if started early, and long-term supplementation may reduce cold incidence — but it should not be used routinely for viral fever or as a standalone treatment for URTI in young children. It does not replace symptomatic care (saline drops, antipyretics), and antibiotics remain contraindicated for uncomplicated viral URTI regardless of zinc use.
This is a shared conversation. Sign in to Orris to start your own chat.